Skip to main content


Latest articles

12-08-2022 | Diabetes | News | Article

Use of sleeve gastrectomy may be valid for some people with class 1 obesity

Study findings published in JAMA Network Open suggest that for people with class 1 obesity, sleeve gastrectomy is associated with greater weight loss and diabetes remission than lifestyle intervention, but the procedure is also linked to increased incidence of substance use disorder and self-harm.

11-08-2022 | Diabetes | News | Article

‘Diverse’ comorbidities characterize people with type 2 diabetes

Only two of the five most common comorbidities identified in a UK population with type 2 diabetes are traditionally associated with the condition, say researchers.

09-08-2022 | Diabetes | News | Article

Lifestyle intervention strategy beneficial for older adults with diabetes

Lifestyle intervention proves “highly successful” in adults with diabetes aged 65 to 85 years, improving both metabolic and functional health, report researchers.

08-08-2022 | Diabetes | News | Article

Daily insulin dose may be linked to cancer risk in type 1 diabetes

People with type 1 diabetes who take a higher daily dose of insulin may have an increased risk for cancer compared with those on lower doses, US researchers report.

05-08-2022 | Diabetes | News | Article

Endoscopic sleeve gastroplasty MERITs consideration for mild-to-moderate obesity

People with mild-to-moderate obesity who undergo minimally invasive endoscopic sleeve gastroplasty in addition to lifestyle intervention achieve greater weight loss and metabolic improvements than those undergoing lifestyle modification alone, show the MERIT trial results.

04-08-2022 | Diabetes | News | Article

SURPASS J trials support tirzepatide use in Japanese people with type 2 diabetes

Tirzepatide is a promising treatment option for Japanese people with type 2 diabetes when used as monotherapy or added to antihyperglycemic agents, show the SURPASS J-mono and SURPASS J-combo trials.

02-08-2022 | Diabetes | News | Article

Increased short-term type 1 diabetes risk post-COVID unlikely to be due to infection

Testing positive for SARS-CoV-2 is associated with an increased risk for incident type 1 diabetes, but this is restricted to the first 30 days post-infection and may be explained by increased testing frequency around the time of diabetes diagnosis, researchers report.

01-08-2022 | Diabetes | News | Article

‘Major improvements’ in diabetes detection in USA

The number of people with undiagnosed diabetes in the USA has fallen in the past 3 decades, indicates research published in Diabetes Care.

29-07-2022 | Diabetes | News | Article

Healthy lifestyle may counteract genetic predisposition to type 2 diabetes

A family history of diabetes is associated with a younger age at type 2 diabetes diagnosis, but this could be delayed by following a healthy lifestyle, suggest data from the Joint Asia Diabetes Evaluation Register.

28-07-2022 | Diabetes | News | Article

No justification for bespoke antihypertensive intervention in type 2 diabetes

The absolute benefit of blood pressure reduction on cardiovascular risk does not differ according to whether or not people have type 2 diabetes, shows an individual participant data meta-analysis.

25-07-2022 | Diabetes | News | Article

Diabetes distress triggers may vary with type of diabetes

Research indicates that despite a lot of overlap, diabetes distress can arise from different experiences according to whether people have type 1 or type 2 diabetes.

22-07-2022 | Diabetes | News | Article

COVID-linked diabetes risk increase short lived

The risk for receiving a new diabetes diagnosis is increased “for at least 12 weeks” after COVID-19 illness, but then declines, say researchers.

21-07-2022 | Diabetes | News | Article

Sotagliflozin effects differ from empagliflozin only at breakfast

The only notable short-term differences in the effects of sotagliflozin and empagliflozin occur in glucose metabolism after breakfast, show findings from a randomized trial.

19-07-2022 | Diabetes | News | Article

Diabetes burden expanding in the Americas

Diabetes burden is large, heterogenous, and has increased across all six regions of the Americas since 1990, mostly as a result of type 2 diabetes, show data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2019.

18-07-2022 | Diabetes | News | Article

Guideline-concordant diabetes screening rates ‘suboptimal’

Women are more likely to attend guideline-recommended diabetes screening than men, but rates are “suboptimal” in both sexes, particularly among younger individuals, show population-based study data from Canada.

15-07-2022 | Diabetes | News | Article

Progressing prediabetes a ‘key turning point’ for white matter damage

Researchers have identified localized white matter microstructural damage in people with prediabetes and widespread abnormalities in those with type 2 diabetes.

14-07-2022 | Diabetes | News | Article

‘Step therapy’ compromise preserves good outcomes in diabetic macular edema

Starting people on bevacizumab and switching to aflibercept only when necessary keeps costs down without compromising treatment efficacy for people with diabetic macular edema, shows a randomized trial.

12-07-2022 | Diabetes | News | Article

10,000 steps per day optimal in diabetes or prediabetes

Even small increases in the number of steps taken in a day is associated with a reduced risk for mortality in people with prediabetes or diabetes, say researchers.

11-07-2022 | Diabetes | News | Article

Morning mindset predicts daily glucose fluctuations in young people with diabetes

Researchers have found that the early morning psychosocial state of adolescents and young adults with type 1 diabetes explains a proportion of their daily variance in time in range.

08-07-2022 | Diabetes | News | Article

Two early childhood autoantibody screenings predict most type 1 diabetes cases

Testing high-risk children for islet autoantibodies twice, at the ages of 2 and 6 years, is sufficient to predict the majority of clinical cases of type 1 diabetes diagnosed by the age of 15, a study suggests.